CD86 and neoplasm: Tumor-derived DAMPs activate myeloid cells, increasing macrophage TNF-α and IL-6 levels and CD86+ fractions; this activation enhances tumor cell proliferation and migration, evidencing a DAMP-macrophage loop that perpetuates necro-inflammation (Eteshola et al., 2021[17]).